Cancer Research Annual Meeting 2010 Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rayala, S. K.
Right arrow Articles by Kumar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rayala, S. K.
Right arrow Articles by Kumar, R.
[Cancer Research 66, 1694-1701, February 1, 2006]
© 2006 American Association for Cancer Research

Experimental Therapeutics, Molecular Targets, and Chemical Biology

P21-Activated Kinase 1 Regulation of Estrogen Receptor-{alpha} Activation Involves Serine 305 Activation Linked with Serine 118 Phosphorylation

Suresh K. Rayala1, Amjad H. Talukder1, Seetharaman Balasenthil1, Robbin Tharakan3, Christopher J. Barnes1, Rui-An Wang1, Marcelo Aldaz2, Sohaib Khan3 and Rakesh Kumar1

Departments of 1 Molecular and Cellular Oncology and 2 Carcinogenesis, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; and 3 Department of Cell Biology, Neurobiology, and Anatomy, Vontz Center for Molecular Studies, University of Cincinnati College of Medicine, Cincinnati, Ohio

Requests for reprints: Rakesh Kumar, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-745-3558; Fax: 713-745-3792; E-mail: rkumar{at}mdanderson.org.

Here, we investigated the role of P21-activated kinase 1 (Pak1) signaling in the function of estrogen receptor-{alpha} (ER-{alpha}) as assessed by serine 305 (S305) activation and transactivation activity of ER. We found that Pak1 overexpression interfered with the antiestrogenic action of tamoxifen upon the ER transactivation function in hormone-sensitive cells. In addition, tamoxifen stimulation led to up-regulation of ER target genes in breast cancer cells with increased Pak1 expression. Tamoxifen also increased Pak1-ER interaction in tamoxifen-resistant but not in tamoxifen-sensitive cells. Results from the mutational studies discovered a role of ER-S305 phosphorylation in triggering a subsequent phosphorylation of serine 118 (S118), and these effects were further potentiated by tamoxifen treatment. We found that S305 activation-linked ER transactivation function requires a functional S118, and active Pak1 signaling is required for a sustaining S118 phosphorylation of the endogenous ER. All of these events were positively influenced by tamoxifen and thus may contribute toward the loss of antiestrogenic effect of tamoxifen. These findings suggest that Pak1 signaling-dependent activation of ER-S305 leads to an enhanced S118 phosphorylation presumably due to a conformational change, and such structural modifications may participate in the development of tamoxifen resistance. (Cancer Res 2006; 66(3): 1694-701)




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. Cheng, X. Kong, H. Wang, H. Gan, Y. Hao, W. Zou, J. Wu, Y. Chi, J. Yang, Y. Hong, et al.
Trihydrophobin 1 Interacts with PAK1 and Regulates ERK/MAPK Activation and Cell Migration
J. Biol. Chem., March 27, 2009; 284(13): 8786 - 8796.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
C. Atsriku, D. J. Britton, J. M. Held, B. Schilling, G. K. Scott, B. W. Gibson, C. C. Benz, and M. A. Baldwin
Systematic Mapping of Posttranslational Modifications in Human Estrogen Receptor-{alpha} with Emphasis on Novel Phosphorylation Sites
Mol. Cell. Proteomics, March 1, 2009; 8(3): 467 - 480.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
P. Bhat-Nakshatri, G. Wang, H. Appaiah, N. Luktuke, J. S. Carroll, T. R. Geistlinger, M. Brown, S. Badve, Y. Liu, and H. Nakshatri
AKT Alters Genome-Wide Estrogen Receptor {alpha} Binding and Impacts Estrogen Signaling in Breast Cancer
Mol. Cell. Biol., December 15, 2008; 28(24): 7487 - 7503.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Naresh, A. D. Thor, S. M. Edgerton, K. C. Torkko, R. Kumar, and F. E. Jones
The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis
Cancer Res., August 1, 2008; 68(15): 6387 - 6395.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M. Zoubir, M. C. Mathieu, C. Mazouni, C. Liedtke, L. Corley, S. Geha, J. Bouaziz, M. Spielmann, F. Drusche, W. F. Symmans, et al.
Modulation of ER phosphorylation on serine 118 by endocrine therapy: a new surrogate marker for efficacy
Ann. Onc., August 1, 2008; 19(8): 1402 - 1406.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. Arpino, L. Wiechmann, C. K. Osborne, and R. Schiff
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
Endocr. Rev., April 1, 2008; 29(2): 217 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
M. Wu, D. R. Soler, M. C. Abba, M. I. Nunez, R. Baer, C. Hatzis, A. Llombart-Cussac, A. Llombart-Bosch, and C. M. Aldaz
CtIP Silencing as a Novel Mechanism of Tamoxifen Resistance in Breast Cancer
Mol. Cancer Res., December 1, 2007; 5(12): 1285 - 1295.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M. W. Mayhew, E. D. Jeffery, N. E. Sherman, K. Nelson, J. M. Polefrone, S. J. Pratt, J. Shabanowitz, J. T. Parsons, J. W. Fox, D. F. Hunt, et al.
Identification of phosphorylation sites in betaPIX and PAK1
J. Cell Sci., November 15, 2007; 120(22): 3911 - 3918.
[Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
W. Zwart, A. Griekspoor, M. Rondaij, D. Verwoerd, J. Neefjes, and R. Michalides
Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor {alpha}
Mol. Cancer Ther., May 1, 2007; 6(5): 1526 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. H. Al-Dhaheri and B. G. Rowan
Protein Kinase A Exhibits Selective Modulation of Estradiol-Dependent Transcription in Breast Cancer Cells that Is Associated with Decreased Ligand Binding, Altered Estrogen Receptor {alpha} Promoter Interaction, and Changes in Receptor Phosphorylation
Mol. Endocrinol., February 1, 2007; 21(2): 439 - 456.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. K. Rayala, P. den Hollander, B. Manavathi, A. H. Talukder, C. Song, S. Peng, A. Barnekow, J. Kremerskothen, and R. Kumar
Essential Role of KIBRA in Co-activator Function of Dynein Light Chain 1 in Mammalian Cells
J. Biol. Chem., July 14, 2006; 281(28): 19092 - 19099.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. K. Rayala, P. R. Molli, and R. Kumar
Nuclear p21-Activated Kinase 1 in Breast Cancer Packs Off Tamoxifen Sensitivity.
Cancer Res., June 15, 2006; 66(12): 5985 - 5988.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. C. Jordan
Pak up your breast tumor--and grow!
J Natl Cancer Inst, May 17, 2006; 98(10): 657 - 659.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
C. Holm, S. Rayala, K. Jirstrom, O. Stal, R. Kumar, and G. Landberg
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.
J Natl Cancer Inst, May 17, 2006; 98(10): 671 - 680.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.